SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.000
0.00 (0.00%)
Jun 4, 2026, 4:04 PM CET
SHL Telemedicine Market Cap
SHL Telemedicine has a market cap or net worth of 37.06 million as of June 4, 2026. Its market cap has increased by 16.24% in one year.
Market Cap
37.06M
Enterprise Value
27.40M
Revenue
46.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since November 14, 2000, SHL Telemedicine's market cap has decreased from 229.59M to 37.06M, a decrease of -83.86%. That is a compound annual growth rate of -6.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 37.06M | -15.25% |
| Dec 30, 2025 | 43.73M | 2.61% |
| Dec 30, 2024 | 42.62M | -62.59% |
| Dec 29, 2023 | 113.92M | -47.37% |
| Dec 30, 2022 | 216.45M | -21.67% |
| Dec 30, 2021 | 276.35M | 121.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 248.62B |
| Novartis AG | 207.80B |
| Galderma Group AG | 38.08B |
| Lonza Group AG | 34.15B |
| Santhera Pharmaceuticals Holding AG | 212.28M |
| BioVersys AG | 159.07M |
| Xlife Sciences AG | 136.85M |
| Molecular Partners AG | 117.03M |